These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24749064)

  • 41. Altered glutamate level and its association with working memory among patients with treatment-resistant schizophrenia (TRS): a proton magnetic resonance spectroscopy study.
    Huang LC; Lin SH; Tseng HH; Chen KC; Abdullah M; Yang YK
    Psychol Med; 2023 May; 53(7):3220-3227. PubMed ID: 35197141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study.
    Iwata Y; Nakajima S; Plitman E; Caravaggio F; Kim J; Shah P; Mar W; Chavez S; De Luca V; Mimura M; Remington G; Gerretsen P; Graff-Guerrero A
    Biol Psychiatry; 2019 Apr; 85(7):596-605. PubMed ID: 30389132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced anterior cingulate cognitive activation is associated with prefrontal-temporal cortical thinning in schizophrenia.
    Schultz CC; Koch K; Wagner G; Nenadic I; Schachtzabel C; Güllmar D; Reichenbach JR; Sauer H; Schlösser RG
    Biol Psychiatry; 2012 Jan; 71(2):146-53. PubMed ID: 21967959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Exploratory Study of Spectroscopic Glutamatergic Correlates of Cortical Excitability in Depressed Adolescents.
    Lewis CP; Port JD; Frye MA; Vande Voort JL; Ameis SH; Husain MM; Daskalakis ZJ; Croarkin PE
    Front Neural Circuits; 2016; 10():98. PubMed ID: 27965544
    [No Abstract]   [Full Text] [Related]  

  • 45. Frontal P3 event-related potential is related to brain glutamine/glutamate ratio measured in vivo.
    Hall MH; Jensen JE; Du F; Smoller JW; O'Connor L; Spencer KM; Öngür D
    Neuroimage; 2015 May; 111():186-91. PubMed ID: 25687595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced resting-state brain functional network connectivity and poor regional homogeneity in patients with CADASIL.
    Su J; Ban S; Wang M; Hua F; Wang L; Cheng X; Tang Y; Zhou H; Zhai Y; Du X; Liu J
    J Headache Pain; 2019 Nov; 20(1):103. PubMed ID: 31711415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia.
    McQueen G; Lally J; Collier T; Zelaya F; Lythgoe DJ; Barker GJ; Stone JM; McGuire P; MacCabe JH; Egerton A
    Psychopharmacology (Berl); 2018 Oct; 235(10):3045-3054. PubMed ID: 30141055
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glutamate metabolites in treatment resistant schizophrenia: A meta-analysis and systematic review of
    Kumar V; Manchegowda S; Jacob A; Rao NP
    Psychiatry Res Neuroimaging; 2020 Jun; 300():111080. PubMed ID: 32279055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study.
    Girgis RR; Baker S; Mao X; Gil R; Javitt DC; Kantrowitz JT; Gu M; Spielman DM; Ojeil N; Xu X; Abi-Dargham A; Shungu DC; Kegeles LS
    Psychiatry Res; 2019 May; 275():78-85. PubMed ID: 30884334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia.
    Gallinat J; McMahon K; Kühn S; Schubert F; Schaefer M
    Schizophr Bull; 2016 Mar; 42(2):425-33. PubMed ID: 26333842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Auditory oddball deficits in schizophrenia: an independent component analysis of the fMRI multisite function BIRN study.
    Kim DI; Mathalon DH; Ford JM; Mannell M; Turner JA; Brown GG; Belger A; Gollub R; Lauriello J; Wible C; O'Leary D; Lim K; Toga A; Potkin SG; Birn F; Calhoun VD
    Schizophr Bull; 2009 Jan; 35(1):67-81. PubMed ID: 19074498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glutamate in dorsolateral prefrontal cortex and auditory verbal hallucinations in patients with schizophrenia: A
    Ćurčić-Blake B; Bais L; Sibeijn-Kuiper A; Pijnenborg HM; Knegtering H; Liemburg E; Aleman A
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Aug; 78():132-139. PubMed ID: 28546056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glutamate connectivity associations converge upon the salience network in schizophrenia and healthy controls.
    McCutcheon RA; Pillinger T; Rogdaki M; Bustillo J; Howes OD
    Transl Psychiatry; 2021 May; 11(1):322. PubMed ID: 34045446
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased conflict- and error-related activity in the anterior cingulate cortex in subjects with schizophrenia.
    Kerns JG; Cohen JD; MacDonald AW; Johnson MK; Stenger VA; Aizenstein H; Carter CS
    Am J Psychiatry; 2005 Oct; 162(10):1833-9. PubMed ID: 16199829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of BDNF Val
    Schweiger JI; Bilek E; Schäfer A; Braun U; Moessnang C; Harneit A; Post P; Otto K; Romanczuk-Seiferth N; Erk S; Wackerhagen C; Mattheisen M; Mühleisen TW; Cichon S; Nöthen MM; Frank J; Witt SH; Rietschel M; Heinz A; Walter H; Meyer-Lindenberg A; Tost H
    Neuropsychopharmacology; 2019 Feb; 44(3):590-597. PubMed ID: 30375508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alterations in neural systems mediating cognitive flexibility and inhibition in mood disorders.
    Piguet C; Cojan Y; Sterpenich V; Desseilles M; Bertschy G; Vuilleumier P
    Hum Brain Mapp; 2016 Apr; 37(4):1335-48. PubMed ID: 26787138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence that altered amygdala activity in schizophrenia is related to clinical state and not genetic risk.
    Rasetti R; Mattay VS; Wiedholz LM; Kolachana BS; Hariri AR; Callicott JH; Meyer-Lindenberg A; Weinberger DR
    Am J Psychiatry; 2009 Feb; 166(2):216-25. PubMed ID: 19074979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis.
    Fusar-Poli P; Stone JM; Broome MR; Valli I; Mechelli A; McLean MA; Lythgoe DJ; O'Gorman RL; Barker GJ; McGuire PK
    Arch Gen Psychiatry; 2011 Sep; 68(9):881-90. PubMed ID: 21536967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Magnetic resonance spectroscopy investigations of functionally defined language areas in schizophrenia patients with and without auditory hallucinations.
    Homan P; Vermathen P; Van Swam C; Federspiel A; Boesch C; Strik W; Dierks T; Hubl D; Kreis R
    Neuroimage; 2014 Jul; 94():23-32. PubMed ID: 24650602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GABA, glutamatergic dynamics and BOLD contrast assessed concurrently using functional MRS during a cognitive task.
    Craven AR; Dwyer G; Ersland L; Kazimierczak K; Noeske R; Sandøy LB; Johnsen E; Hugdahl K
    NMR Biomed; 2024 Mar; 37(3):e5065. PubMed ID: 37897259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.